2024 Q2 Form 10-Q Financial Statement
#000165731224000014 Filed on May 10, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $49.04M | $20.43M |
| YoY Change | 294.17% | 113.08% |
| % of Gross Profit | ||
| Research & Development | $19.39M | $6.764M |
| YoY Change | 1631.07% | -46.36% |
| % of Gross Profit | ||
| Depreciation & Amortization | $270.0K | $263.0K |
| YoY Change | 71.97% | 67.52% |
| % of Gross Profit | ||
| Operating Expenses | $68.42M | $27.20M |
| YoY Change | 586.63% | 22.52% |
| Operating Profit | -$68.42M | -$27.20M |
| YoY Change | 586.63% | 22.52% |
| Interest Expense | $1.757M | $1.586M |
| YoY Change | 137.43% | 441.3% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$1.398M | $2.158M |
| YoY Change | -195.23% | -61.66% |
| Pretax Income | -$69.82M | -$25.04M |
| YoY Change | 721.71% | 51.12% |
| Income Tax | $1.014M | $754.0K |
| % Of Pretax Income | ||
| Net Earnings | -$70.84M | -$25.79M |
| YoY Change | 704.3% | 54.06% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | -$0.11 | -$0.04 |
| Diluted Earnings Per Share | -$0.11 | -$0.04 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 648.7M shares | 646.5M shares |
| Diluted Shares Outstanding | 648.2M shares | 645.7M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $404.6M | $254.9M |
| YoY Change | 49.45% | -12.54% |
| Cash & Equivalents | $404.6M | $254.9M |
| Short-Term Investments | ||
| Other Short-Term Assets | $2.576M | $1.875M |
| YoY Change | -57.49% | -9.55% |
| Inventory | ||
| Prepaid Expenses | $5.433M | $3.622M |
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $416.3M | $271.8M |
| YoY Change | 44.63% | -11.42% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $44.00K | $22.00K |
| YoY Change | 300.0% | 83.33% |
| Goodwill | $545.0K | $545.0K |
| YoY Change | 0.0% | 0.0% |
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $15.00M | $15.00M |
| YoY Change | 0.0% | 0.0% |
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $17.83M | $18.07M |
| YoY Change | 10.77% | 11.18% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $416.3M | $271.8M |
| Total Long-Term Assets | $17.83M | $18.07M |
| Total Assets | $434.1M | $289.9M |
| YoY Change | 42.84% | -10.28% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $4.152M | $4.651M |
| YoY Change | 66.55% | -35.73% |
| Accrued Expenses | $19.63M | $8.269M |
| YoY Change | 162.89% | -53.29% |
| Deferred Revenue | $21.32M | |
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $48.35M | $14.77M |
| YoY Change | 341.56% | -44.3% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $119.7M | $48.55M |
| YoY Change | 502.74% | 145.07% |
| Other Long-Term Liabilities | $97.82M | $1.604M |
| YoY Change | 325953.33% | 2367.69% |
| Total Long-Term Liabilities | $217.5M | $50.15M |
| YoY Change | 993.69% | 152.34% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $48.35M | $14.77M |
| Total Long-Term Liabilities | $217.5M | $50.15M |
| Total Liabilities | $265.8M | $64.92M |
| YoY Change | 762.14% | 39.93% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$485.3M | -$414.4M |
| YoY Change | 35.14% | 18.37% |
| Common Stock | $42.77M | $42.77M |
| YoY Change | 2.44% | 2.44% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $1.203M | $1.282M |
| YoY Change | 23.38% | 6.13% |
| Treasury Stock Shares | ||
| Shareholders Equity | $168.3M | $225.0M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $434.1M | $289.9M |
| YoY Change | 42.84% | -10.28% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$70.84M | -$25.79M |
| YoY Change | 704.3% | 54.06% |
| Depreciation, Depletion And Amortization | $270.0K | $263.0K |
| YoY Change | 71.97% | 67.52% |
| Cash From Operating Activities | -$17.10M | -$13.61M |
| YoY Change | -19.75% | 135.39% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $29.00K | $16.00K |
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | -$29.00K | -$16.00K |
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 166.8M | -$3.123M |
| YoY Change | 134441.94% | -104.55% |
| NET CHANGE | ||
| Cash From Operating Activities | -17.10M | -$13.61M |
| Cash From Investing Activities | -29.00K | -$16.00K |
| Cash From Financing Activities | 166.8M | -$3.123M |
| Net Change In Cash | 149.7M | -$16.89M |
| YoY Change | -806.57% | -126.56% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$17.10M | -$13.61M |
| Capital Expenditures | $29.00K | $16.00K |
| Free Cash Flow | -$17.13M | -$13.63M |
| YoY Change | -19.61% | 135.66% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1118000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1180000 | usd |
| CY2024Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
736000 | usd |
| CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
435000 | usd |
| CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14774000 | usd |
| CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8692000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
48546000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
48374000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1604000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1775000 | usd |
| CY2024Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
50150000 | usd |
| CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
50149000 | usd |
| CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
64924000 | usd |
| CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
58841000 | usd |
| CY2024Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
| CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
| CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.05 | |
| CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.05 | |
| CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
667659630 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
667659630 | shares |
| CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
647372062 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
643536094 | shares |
| CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
42771000 | usd |
| CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
42771000 | usd |
| CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
602497000 | usd |
| CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
601063000 | usd |
| CY2024Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
1282000 | usd |
| CY2023Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
1517000 | usd |
| CY2024Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-4601000 | usd |
| CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-4601000 | usd |
| CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-414397000 | usd |
| CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-388433000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
224988000 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
249283000 | usd |
| CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
289912000 | usd |
| CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
308124000 | usd |
| CY2024Q1 | vrna |
Research And Development Expense Net Of Adjustments
ResearchAndDevelopmentExpenseNetOfAdjustments
|
6764000 | usd |
| CY2023Q1 | vrna |
Research And Development Expense Net Of Adjustments
ResearchAndDevelopmentExpenseNetOfAdjustments
|
12610000 | usd |
| CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
20434000 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
9589000 | usd |
| CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
27198000 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
22199000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27198000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-22199000 | usd |
| CY2024Q1 | vrna |
Gain Loss From Research And Development Tax Credit
GainLossFromResearchAndDevelopmentTaxCredit
|
585000 | usd |
| CY2023Q1 | vrna |
Gain Loss From Research And Development Tax Credit
GainLossFromResearchAndDevelopmentTaxCredit
|
2313000 | usd |
| CY2024Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
3378000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
2677000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
1586000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
293000 | usd |
| CY2024Q1 | vrna |
Foreign Currency Transaction Gain Loss Before Tax Excluding Finance Leases
ForeignCurrencyTransactionGainLossBeforeTaxExcludingFinanceLeases
|
-219000 | usd |
| CY2023Q1 | vrna |
Foreign Currency Transaction Gain Loss Before Tax Excluding Finance Leases
ForeignCurrencyTransactionGainLossBeforeTaxExcludingFinanceLeases
|
932000 | usd |
| CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2158000 | usd |
| CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
5629000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-25040000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-16570000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
754000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
173000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-25794000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16743000 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
645701000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
645701000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
621451000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
621451000 | shares |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
249283000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-25794000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
816000 | usd |
| CY2024Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
3338000 | usd |
| CY2024Q1 | vrna |
Adjustments To Additional Paid In Capital Reclassification From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalReclassificationFromShareBasedCompensation
|
237000 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4258000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
224988000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
230466000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1827000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4290000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
276749000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-25794000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16743000 | usd |
| CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-219000 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
932000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
82000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
73000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
90000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
18000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4258000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4290000 | usd |
| CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
263000 | usd |
| CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
157000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
5000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-938000 | usd |
| CY2024Q1 | vrna |
Increase Decrease In Tax And Tax Credit Receivables Current
IncreaseDecreaseInTaxAndTaxCreditReceivablesCurrent
|
585000 | usd |
| CY2023Q1 | vrna |
Increase Decrease In Tax And Tax Credit Receivables Current
IncreaseDecreaseInTaxAndTaxCreditReceivablesCurrent
|
2313000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-942000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-1362000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1255000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
4327000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
4762000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
3951000 | usd |
| CY2024Q1 | vrna |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-152000 | usd |
| CY2023Q1 | vrna |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-165000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
754000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
141000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
301000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-886000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-13610000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5782000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
16000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-16000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
56862000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
9996000 | usd |
| CY2024Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
364000 | usd |
| CY2023Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | usd |
| CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
3575000 | usd |
| CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
816000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1827000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3123000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
68685000 | usd |
| CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-141000 | usd |
| CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
685000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-16890000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
63588000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
271772000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
227827000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
254882000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
291415000 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
933000 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
244000 | usd |
| CY2024Q1 | vrna |
Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
|
1 | subsidiary |
| CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-414400000 | usd |
| CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
| CY2024Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | segment |
| CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3585000 | usd |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">Use of estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The preparation of interim unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these unaudited condensed consolidated financial statements include, but are not limited to, the accrual and prepayment of research and development expenses and the fair value of share-based compensation. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known, and actual results could differ from the Company’s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">Recently issued accounting standards not yet adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The amendments in this ASU are effective for annual periods beginning on December 15, 2024, and should be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. This ASU will have no impact on the Company's Consolidated Balance Sheets or Consolidated Statements of Operations and Comprehensive Loss. The Company is currently evaluating the impact to its income tax disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">In November 2023, the FASB issued ASU No. 2023-07, Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable investors to better understand an entity's overall performance and assess potential future cash flows. The amendments in this ASU are effective for annual periods beginning on December 15, 2023 and interim periods beginning on December 15, 2024 and should be applied on a retrospective basis for all periods presented. This ASU will have no impact on the Company's Consolidated Balance Sheets or Consolidated </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Statements of Operations and Comprehensive Loss. The Company is currently evaluating the impact to its segment disclosures.</span></div> | |
| CY2024Q1 | vrna |
Accrued Research And Development Fees Current
AccruedResearchAndDevelopmentFeesCurrent
|
1182000 | usd |
| CY2023Q4 | vrna |
Accrued Research And Development Fees Current
AccruedResearchAndDevelopmentFeesCurrent
|
752000 | usd |
| CY2024Q1 | vrna |
Accrued Professional Fees Listing And General Corporate Costs Current
AccruedProfessionalFeesListingAndGeneralCorporateCostsCurrent
|
4402000 | usd |
| CY2023Q4 | vrna |
Accrued Professional Fees Listing And General Corporate Costs Current
AccruedProfessionalFeesListingAndGeneralCorporateCostsCurrent
|
2039000 | usd |
| CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2685000 | usd |
| CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
794000 | usd |
| CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
8269000 | usd |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4258000 | usd |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4290000 | usd |
| CY2024Q1 | dei |
Entity Listing Depository Receipt Ratio
EntityListingDepositoryReceiptRatio
|
8 | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
24689624 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2432000 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
64000 | shares |
| CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1037424 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
26020200 | shares |
| CY2024Q1 | dei |
Entity Listing Depository Receipt Ratio
EntityListingDepositoryReceiptRatio
|
8 | |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-25794000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16743000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
645701000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
645701000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
621451000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
621451000 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
| CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
51900000 | shares |
| CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
51900000 | shares |
| CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
49500000 | shares |
| CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
49500000 | shares |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |
